- Home
- EXEL vs SKLZ Comparison
EXEL vs SKLZ Comparison
Compare EXEL & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | SKLZ |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 78.0M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | SKLZ |
|---|---|---|
| Price | $46.18 | $4.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 1 |
| Target Price | ★ $45.18 | $14.00 |
| AVG Volume (30 Days) | ★ 2.6M | 77.3K |
| Earning Date | 02-10-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,288,218,000.00 | $92,256,000.00 |
| Revenue This Year | $9.79 | $13.33 |
| Revenue Next Year | $12.01 | $12.68 |
| P/E Ratio | $18.38 | ★ N/A |
| Revenue Growth | ★ 9.93 | N/A |
| 52 Week Low | $31.90 | $3.54 |
| 52 Week High | $49.62 | $9.11 |
Technical Indicators
Market Signals| Indicator | EXEL | SKLZ |
|---|---|---|
| Relative Strength Index (RSI) | 61.13 | 28.70 |
| Support Level | $41.93 | $4.23 |
| Resistance Level | $47.24 | $4.60 |
| Average True Range (ATR) | 1.28 | 0.23 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 79.33 | 14.95 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About SKLZ Skillz Inc.
Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. The company's reportable business segments are: the Skillz segment and the Aarki segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is an artificial intelligence company that delivers advertising solutions. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The majority of its revenue is generated from the Skillz segment. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.